CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/27/2021
Back to search
Official data from USPTO
UNITHER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
UNITHER
ST13
US500000077347088Class
5, 10, 42
Filing
77347088
Registration
3629454
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
56
Latest update
04/07/2023
Trademark type
Word
Nice classes
5, 10, 42
Filing date
12/07/2007
Registration date
06/02/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/22/2015
Last transaction
04/07/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
F-80084 AMIENS CEDEX 2, FR
Examiner
FRAZIER,TAMARA G
Law office
M70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
U. P. (pessoa física)
U. D. (pessoa física)
Representatives
Rebeccah Gan Muncy, Geissler, Olds & Lowe, P.C.
Technical classification
Nice Classes
Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical antitussive-cold preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparationsanticoagulants; Pharmaceutical preparationsantidepressants; Pharmaceutical preparationsappetite suppressants; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical sedative preparations; Pharmaceutical preparations for use in urology; Yeast or yeast extracts for medical or pharmaceutical purposes; Pharmaceutical products for ophthalmologic use; Pharmaceutical preparations for wounds; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for human skincare; Anti-diabetic pharmaceuticals; Pharmaceutical antiseptic preparations; Pharmaceutical preparationsa drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparationsa drug delivery system comprising oral alcoholic liquid for per lingual release of a wide variety of therapeutic agents; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Unit dose capsules sold empty for pharmaceutical use
Class 10
Aerosol dispensers for medical use; Dropper bottles for administering medicationsold empty; Droppers for administering medicationsold empty; Drug delivery systems; Use dose bottles and capsules for per lingual delivering medication
Class 42
Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Pharmaceutical product evaluation; Pharmaceutical research and development; Research and development of pharmaceutical capsules for pharmaceutical use * Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Pharmaceutical product evaluation; Pharmaceutical research and development; Research and development of pharmaceutical capsules for pharmaceutical use; all of the foregoing for use in connection with custom manufacturing of pharmaceuticals or packaging for third parties *
Publications
History of USPTO decisions and trademark events.
56 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/27/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/27/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/27/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/27/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/16/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/16/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/16/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/16/2021
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED
07/05/2019
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
07/05/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/05/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/05/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/28/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
05/28/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/02/2018
TMBN
TTAB RELEASE CASE TO TRADEMARKS
12/22/2015
CANT
CANCELLATION TERMINATED NO. 999999
12/22/2015
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
11/20/2015
PLGL
ASSIGNED TO PARALEGAL
11/20/2015
CAND
CANCELLATION DENIED NO. 999999
11/20/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/16/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/16/2015
CORV
REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
08/03/2015
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/30/2015
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
05/28/2015
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
05/28/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/20/2015
ES8R
TEAS SECTION 8 RECEIVED
05/18/2015
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/19/2014
PETC
CANCELLATION INSTITUTED NO. 999999
06/02/2014
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/04/2014
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/04/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
06/02/2009
PUBO
PUBLISHED FOR OPPOSITION
03/17/2009
NPUB
NOTICE OF PUBLICATION
02/25/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/10/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/06/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/03/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/02/2009
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/02/2009
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
01/27/2009
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
01/22/2009
CNSL
LETTER OF SUSPENSION MAILED
07/22/2008
CNSL
SUSPENSION LETTER WRITTEN
07/21/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/03/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/03/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/03/2008
CNRT
NON-FINAL ACTION MAILED
03/19/2008
CNRT
NON-FINAL ACTION WRITTEN
03/19/2008
DOCK
ASSIGNED TO EXAMINER
03/17/2008
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/16/2008
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
03/06/2008
ALIE
ASSIGNED TO LIE
03/06/2008
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
02/07/2008
NWAP
NEW APPLICATION ENTERED
12/12/2007
Continuous trademark protection
Get notified about every new filing that threatens UNITHER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.